Life Sciences BPO Market Report 2026

Life Sciences BPO Market Overview

• Life Sciences BPO market size has reached to $294.54 billion in 2025 • Expected to grow to $481.84 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Crucial Role Of Clinical Trials Support In Driving Growth Of Life Sciences Bpo Market • Market Trend: Strategic Partnerships Driving Innovation in the Life Sciences BPO Market • Asia-Pacific was the largest region in 2025.

What Is Covered Under Life Sciences BPO Market?

Life sciences BPO (business process outsourcing) refers to a service that supports life sciences companies in various areas of their business processes. It is delegating specialized tasks such as data management, regulatory adherence, and customer support associated with the life sciences sector to third-party experts. The main types of services included in life sciences BPO are pharmaceutical outsourcing, medical device outsourcing, contract sales and marketing outsourcing, and others. Pharmaceutical outsourcing refers to the practice where pharmaceutical companies delegate specific tasks or functions related to the drug development, manufacturing, and distribution processes to external service providers. These are used for several applications, including clinical testing methods, environmental testing methods, and others, which are used by various end-users, including hospitals and clinics, diagnostic laboratories, and others.

What Is The Life Sciences BPO Market Growth Forecast?

The life sciences bpo market size is expected to see rapid growth in the next few years. It will grow to $481.84 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing focus on cost efficiency, growing global clinical trial volumes, rising demand for scalable support services, expansion of life sciences companies in emerging markets, higher emphasis on faster product commercialization. Major trends in the forecast period include rising outsourcing of non-core life sciences operations, growing demand for regulatory and compliance support services, increasing adoption of end-to-end bpo solutions, expansion of pharmacovigilance and data management services, rising preference for cost-optimized global delivery models.

Global Life Sciences BPO Market Segmentation

1) By Services: Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales And Marketing Outsourcing, Other Services 2) By Application Area: Clinical Operations, Regulatory And Compliance Operations, Commercial And Market Access Operations, Safety And Pharmacovigilance Operations, Data And Digital Operations 3) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs) Subsegments: 1) By Pharmaceutical Outsourcing: Drug Development Services, Clinical Trials Management, Regulatory Affairs Services, Pharmacovigilance 2) By Medical Devices Outsourcing: Product Development Services, Regulatory Compliance, Quality Assurance And Testing, Supply Chain Management 3) By Contract Sales And Marketing Outsourcing: Sales Force Outsourcing, Marketing Strategy Development, Market Access And Pricing Strategies, Promotional Activities 4) By Other Services: Data Management And Analytics, IT Services, Training And Education, Consulting Services

What Is The Driver Of The Life Sciences BPO Market?

The clinical trials support is expected to propel the growth of the life sciences BPO market going forward. Clinical trials support refers to the services and activities provided to facilitate and manage clinical trials, which are research studies involving human participants to evaluate the safety and effectiveness of new medical treatments, drugs, therapies, medical devices, or interventions. Clinical trials support professionals help maintain the quality and integrity of clinical trial data, ensuring that it meets regulatory standards. This commitment to data quality is essential for BPO providers handling clinical trial data, which is often a core service offered to life sciences companies. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, highlighted that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the clinical trials support is driving the growth of the life sciences BPO industry.

Key Players In The Global Life Sciences BPO Market

Major companies operating in the life sciences bpo market are Accenture plc, Atos SE, Covance Inc., Genpact Ltd., ICON plc, Infosys Ltd., PAREXEL International Corp., IQVIA Holdings Inc., International Business Machines Corp., Cognizant Technology Solutions, Syneos Health Inc., Charles River Laboratories International Inc., WuXi AppTec Co. Ltd., Medpace Holdings Inc., Pharmaceutical Product Development LLC, Medidata Solutions, Health Decisions Inc., Bioclinica Inc., Navitas Life Sciences Private Limited, SGS SA, PRA Health Sciences Inc., Clinipace Worldwide, ClinTec International Ltd., Cromsource Ltd.

Global Life Sciences BPO Market Trends and Insights

Major companies operating in the life sciences bpo market are adopting strategic partnerships approach to develop innovative solutions. Strategic partnerships help life sciences bpo companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach, and accelerating commercialization, ultimately driving innovation and growth in the life sciences bpo industry. For instance, in March 2024, Cognizant Technology Solutions Corp, a US-based company, partnered with NVIDIA, a US-based software company. With this partnership, Cognizant and NVIDIA aim to accelerate drug discovery by utilizing NVIDIA's BioNeMo generative AI platform, enabling faster and more efficient analysis of complex datasets. This collaboration seeks to enhance research capabilities and expedite the development of life-saving treatments.

What Are Latest Mergers And Acquisitions In The Life Sciences BPO Market?

In January 2025, NVIDIA Corporation, a US-based technology company, partnered with IQVIA Holdings Inc. to accelerate AI-driven transformation across healthcare and life sciences. With this partnership, NVIDIA Corporation and IQVIA Holdings Inc. aim to enhance drug discovery, clinical development, and commercial analytics by integrating NVIDIA’s advanced AI Foundry services with IQVIA’s extensive real-world data resources to deliver faster insights, improve decision-making, and support the development of innovative therapies. IQVIA Holdings Inc. is a US-based healthcare analytics company that specializes in providing real-world data, AI-powered platforms, and advanced analytical solutions for the life-sciences sector.

Regional Outlook

Asia-Pacific was the largest region in the life sciences BPO market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Life Sciences BPO Market?

The life sciences BPO market includes revenues earned by entities by providing research and analytics, digital transformation, finance and accounting, and procurement. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Life Sciences BPO Market Report 2026?

The life sciences bpo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the life sciences bpo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.